Table 1.
Patient demographic, clinical, and baseline angiographic data
| Number of patients | 316 |
| Number of vessels | 427 |
| Number of men | 224 (71%) |
| Age (years)* | 58.6 (6) |
| Number aged >70 years | 97 (31%) |
| Risk factors | |
| Smoking | 222 (70%) |
| Diabetes | 56 (18%) |
| Hypercholesterolaemia | 199 (63%) |
| Hypertension | 145 (46%) |
| Family history | 153 (48%) |
| CCS functional class | |
| I | 16 (5%) |
| II | 155 (49%) |
| III | 145 (46%) |
| IV | 0 |
| Drug treatment | |
| Aspirin | 310 (98%) |
| β Blocker | 183 (58%) |
| ACE inhibitor | 155 (49%) |
| Calcium antagonist | 107 (34%) |
| Nitrate | 186 (59%) |
| Statin | 151 (48%) |
| LV function | |
| Good (EF >50%) | 255 (81%) |
| Moderate (EF 30–50%) | 53 (17%) |
| Poor (EF <35%) | 8 (2%) |
| Target vessel | |
| LAD | 211 (49%) |
| LCx | 84 (20%) |
| RCA | 132 (31%) |
| ACC/AHA lesion type: | |
| A | 124 (29%) |
| B | 167 (39%) |
| C | 136 (32%) |
*Mean (SD).
ACC, American College of Cardiology; ACE, angiotensin converting enzyme; AHA, American Heart Association; CCS, Canadian Cardiovascular Society; EF, ejection fraction; LAD, left anterior descending artery; LCx, left circumflex coronary artery; LV, left ventricle; RCA, right coronary artery.